Daniel F Hayes

Daniel F Hayes

UNVERIFIED PROFILE

Are you Daniel F Hayes?   Register this Author

Register author
Daniel F Hayes

Daniel F Hayes

Publications by authors named "Daniel F Hayes"

Are you Daniel F Hayes?   Register this Author

100Publications

3461Reads

9Profile Views

Clinical Applications of Circulating Tumor Cells in Breast Cancer.

Recent Results Cancer Res 2020 ;215:147-160

Department of Internal Medicine, Breast Oncology Program of the Comprehensive Cancer Center, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109-5942, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-26439-0_8DOI Listing
October 2019

Completing the Translation.

Oncologist 2019 Oct 16. Epub 2019 Oct 16.

University of Michigan Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0650DOI Listing
October 2019

HER2 and Breast Cancer - A Phenomenal Success Story.

Authors:
Daniel F Hayes

N Engl J Med 2019 09 10;381(13):1284-1286. Epub 2019 Sep 10.

From the University of Michigan Rogel Cancer Center, Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcibr1909386DOI Listing
September 2019

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.

N Engl J Med 2019 06 3;380(25):2395-2405. Epub 2019 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); University of Texas, San Antonio (P.M.R.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O., J.A.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); the National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and the University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and the University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1904819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709671PMC
June 2019

Factors influencing the use of extended adjuvant endocrine therapy.

Breast Cancer Res Treat 2019 May 31;175(1):181-189. Epub 2019 Jan 31.

Division of Oncology, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Dr., #5513, Salt Lake City, UT, 84112, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-019-05145-8
Publisher Site
http://dx.doi.org/10.1007/s10549-019-05145-8DOI Listing
May 2019

A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells.

Nat Commun 2019 04 1;10(1):1478. Epub 2019 Apr 1.

Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09439-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443676PMC
April 2019

Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer.

N Engl J Med 2019 03;380(13):1226-1234

From the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange (R.S.M.); the SWOG Statistics and Data Management Center (W.E.B., D.L.L.) and Seattle Cancer Care Alliance and University of Washington Medical Center (J.R.G., H.H.L.) - both in Seattle; Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); London Health Sciences Centre and the National Cancer Institute of Canada Clinical Trials Group, London, ON, Canada (T.A.V.); the Cancer Center of Kansas and Wichita National Cancer Institute Community Oncology Research Program (NCORP), Wichita (S.R.D.); Kaiser Permanente NCORP, Portland, OR (N.R.T.); the University of Michigan, Ann Arbor (D.F.H.); the University of Arizona Cancer Center, Tucson (R.B.L.); and the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1811714DOI Listing
March 2019

Further Progress for Patients with Breast Cancer.

Authors:
Daniel F Hayes

N Engl J Med 2019 02;380(7):676-677

From the University of Michigan Rogel Cancer Center, Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1816059DOI Listing
February 2019

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Arch Pathol Lab Med 2018 10 5;142(10):1242-1253. Epub 2018 Mar 5.

Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Alexander J. Lazar and Apostolia M. Tsimberidou, The University of Texas MD Anderson Cancer Center, Houston, TX; hristina M. Lockwood, University of Washington, Seattle, WA; Alex J. Rai, Columbia University Medical Center, New York, NY; Patricia Vasalos and Brooke L. Billman, College of American Pathologists, Northfield, IL; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Nicholas C. Turner, Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-090
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0901-SADOI Listing
October 2018

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2018 Jul 3;379(2):111-121. Epub 2018 Jun 3.

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.), and McMaster University, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Chicago Stritch School of Medicine, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), and Duke University Medical Center, Durham (J.A.O.) - both in North Carolina; Mayo Clinic, Jacksonville, FL (M.P.G.); National Institutes of Health, National Cancer Institute, Bethesda, MD (T.L., J.A.); Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.), Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Washington University, St. Louis (M.J.E.); National Surgical Adjuvant Breast and Bowel Project Pathology Office (S.P.) and University of Pittsburgh (A.M.B.), Pittsburgh; Emory University, Atlanta (W.C.W.); University of Texas, San Antonio (P.M.R.); Cancer Trials Ireland, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); and University of Hawaii Cancer Center, Honolulu (J.L.B.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804710
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172658PMC
July 2018

Precision Medicine and Testing for Tumor Biomarkers-Are All Tests Born Equal?

Authors:
Daniel F Hayes

JAMA Oncol 2018 06;4(6):773-774

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2017.4018DOI Listing
June 2018

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

J Clin Oncol 2018 06 5;36(16):1631-1641. Epub 2018 Mar 5.

Jason D. Merker and Maximilian Diehn, Stanford University School of Medicine; Stanford, CA; Geoffrey R. Oxnard, Dana Farber Cancer Institute and Harvard Medical School; Neal Lindeman, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Carolyn Compton, Arizona State University, Tempe, AZ; Patricia Hurley, Richard L. Schilsky, Thomas K. Oliver, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Alexander J. Lazar and Apostolia M. Tsimberidou, The University of Texas MD Anderson Cancer Center, Houston, TX; Christina M. Lockwood, University of Washington, Seattle, WA; Alex J. Rai, Columbia University Medical Center, New York, NY; Patricia Vasalos and Brooke L. Billman, College of American Pathologists, Northfield, IL; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Nicholas C. Turner, Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8671DOI Listing
June 2018

Disseminated breast tumour cells: biological and clinical meaning.

Nat Rev Clin Oncol 2018 03 21;15(3):129-131. Epub 2017 Nov 21.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, 1500 East Medical Center, Ann Arbor, Michigan 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.174DOI Listing
March 2018

Breast-Cancer Recurrence after Stopping Endocrine Therapy.

N Engl J Med 2018 03;378(9):870-871

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1715968DOI Listing
March 2018

Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement.

J Clin Oncol 2018 02 13;36(6):617-623. Epub 2017 Dec 13.

Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8193DOI Listing
February 2018

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

N Engl J Med 2017 11;377(19):1836-1846

From the Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford (H.P., R.G., J. Braybrooke, C.D., C.T., P.M., R.P.), and Royal Marsden Hospital and Institute of Cancer Research, London (M.D.) - both in the United Kingdom; Sunnybrook Health Sciences Centre and the University of Toronto, Toronto (K.I.P.); Karolinska Institutet and Karolinska University Hospital, Stockholm (J. Bergh); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (D.F.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734609PMC
November 2017

American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce.

J Clin Oncol 2017 Aug 1;35(22):2576-2579. Epub 2017 May 1.

Karen M. Winkfield, Wake Forest Baptist Medical Center, Winston-Salem, NC; Christopher R. Flowers, Winship Cancer Institute, Emory University; Otis W. Brawley, American Cancer Society, Atlanta, GA; Jyoti D. Patel, University of Chicago, Chicago; Patricia Robinson, Loyola University Medical Center, Maywood, IL; Gladys Rodriguez, South Texas Oncology and Hematology, San Antonio, TX; Amit Agarwal, University of Arizona, Tucson, AZ; Lori Pierce and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; Edith P. Mitchell, Thomas Jefferson University Hospital, Philadelphia, PA; and Kimberly T. Head-Smith and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.1372DOI Listing
August 2017

Making a Difference in Cancer Care With You.

Authors:
Daniel F Hayes

J Clin Oncol 2017 08 5;35(24):2723-2728. Epub 2017 Jul 5.

Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5703DOI Listing
August 2017

Considerations for Implementation of Cancer Molecular Diagnostics Into Clinical Care.

Authors:
Daniel F Hayes

Am Soc Clin Oncol Educ Book 2016 ;35:292-6

From the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_160236DOI Listing
January 2017

Comparative analysis of circulating tumor DNA stability In KEDTA, Streck, and CellSave blood collection tubes.

Clin Biochem 2016 Dec 27;49(18):1354-1360. Epub 2016 Apr 27.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA; Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA; Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2016.03.012DOI Listing
December 2016

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes.

J Clin Oncol 2016 11;34(31):3796-3802

Julie M. Vose, University of Nebraska, Omaha, NE; Laura A. Levit, Patricia Hurley, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Carrie Lee, University of North Carolina at Chapel Hill, Chapel Hill, NC; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Teresa Stewart, New Mexico Cancer Care Alliance, Albuquerque, NM; Janie Hofacker, Association of American Cancer Institutes, Pittsburgh, PA; and Daniel F. Hayes, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.6781DOI Listing
November 2016

Innovations in American Society of Clinical Oncology Practice Guideline Development.

J Clin Oncol 2016 09 5;34(26):3213-20. Epub 2016 Jul 5.

Mark R. Somerfield, Kari Bohlke, Kaitlin Einhaus, Robert S. Miller, Thomas K. Oliver, and Eduardo Ortiz, American Society of Clinical Oncology, Alexandria; Neelima Denduluri, U.S. Oncology Network, Virginia Cancer Specialists, Arlington, VA; George P. Browman, McMaster University, Hamilton, Ontario; University of British Columbia, Vancouver, British Columbia, Canada; Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Alok A. Khorana, Cleveland Clinic, Cleveland, OH; Supriya G. Mohile, University of Rochester, Rochester, NY; and Gary H. Lyman, Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.3524DOI Listing
September 2016

ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors.

Physiol Genomics 2016 09 19;48(9):688-98. Epub 2016 Aug 19.

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/physiolgenomics.00065.2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111879PMC
September 2016

Circulating Tumor Cells.

Adv Exp Med Biol 2016 ;882:235-58

Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan Health and Hospital System, 6312 Cancer Center University of Michigan, 1500 Medical Center Drive, 48109, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-22909-6_10DOI Listing
August 2016

Personalized Medicine: Genomics Trials in Oncology.

Trans Am Clin Climatol Assoc 2015 ;126:133-43

Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530676PMC
June 2016

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2016 Apr 8;34(10):1134-50. Epub 2016 Feb 8.

Lyndsay N. Harris, Case Western Reserve University, Cleveland, OH; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Lisa M. McShane, National Cancer Institute, Bethesda, MD; Fabrice Andre, Institute Gustave Roussy, Paris, France; Deborah E. Collyar, Patient Advocates in Research; Elizabeth H. Hammond, University of Utah and Intermountain Health Care, Salt Lake City, UT; Ana M. Gonzalez-Angulo and Robert C. Bast, The University of Texas MD Anderson Cancer Center, Houston; Robert G.Mennel, Baylor University Medical Center and Texas Oncology PA, Dallas, TX; Nicole M. Kuderer, University of Washington Medical Center, Seattle, WA; Minetta C. Liu, Mayo Clinic College of Medicine, Rochester, MN; and Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/02/05/JCO.2015.65
Web Search
http://www.instituteforquality.org/sites/instituteforquality
Web Search
http://www.instituteforquality.org/sites/instituteforquality
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.65.2289
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.2289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933134PMC
April 2016

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.

J Oncol Pract 2016 Apr 8;12(4):384-9. Epub 2016 Mar 8.

Case Western Reserve University, Cleveland, OH; American Society of Clinical Oncology, Alexandria, VA; National Cancer Institute, Bethesda, MD; and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.010868DOI Listing
April 2016

ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.

Clin Cancer Res 2016 Feb 10;22(4):993-9. Epub 2015 Aug 10.

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland. The Whiting School of Engineering, Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0943DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993201PMC
February 2016

Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2016 Feb 13;155(3):589-95. Epub 2016 Feb 13.

Internal Medicine/Hematology/Oncology, University of Michigan Medical School, 1500 East Medical Center Dr, Med Inn Bldg C450, Ann Arbor, MI, 48109-5843, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3705-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895232PMC
February 2016

Is Breast Cancer a Curable Disease?

Authors:
Daniel F Hayes

J Oncol Pract 2016 Jan;12(1):13-6

The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.009332DOI Listing
January 2016

Clinical utility of genetic signatures in selecting adjuvant treatment: Risk stratification for early vs. late recurrences.

Authors:
Daniel F Hayes

Breast 2015 Nov 1;24 Suppl 2:S6-S10. Epub 2015 Aug 1.

Breast Oncology Program, 6312 Cancer Center University of Michigan, 1500 Medical Center Drive Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.07.002DOI Listing
November 2015

Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.

Mol Oncol 2015 Nov 29;9(9):1868-76. Epub 2015 Jul 29.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Health System, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624024PMC
November 2015

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity.

J Clin Oncol 2015 Nov 31;33(31):3533-4. Epub 2015 Aug 31.

The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.3628DOI Listing
November 2015

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2015 Nov 27;373(21):2005-14. Epub 2015 Sep 27.

From the Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (J.A.S., D.F.M.); Dana-Farber Cancer Institute, Boston (R.J.G.); Sunnybrook Research Institute, Toronto (K.I.P.) and Juravinski Cancer Center, Hamilton, ON (T.J.W.) - both in Canada; Loyola University Medical Center, Maywood (K.S.A.), and Northwestern University, Chicago (L.I.W., V.G.K.) - both in Illinois; University of Michigan, Ann Arbor (D.F.H.); Virginia Commonwealth University School of Medicine and the Massey Cancer Center, Richmond (C.E.G.); University of North Carolina, Chapel Hill (E.C.D.), Duke University Medical Center, Durham (J.A.O.), Wake Forest University Health Service, Winston-Salem (L.I.W.), and Southeast Clinical Oncology Research Consortium, Goldsboro (J.N.A.) - all in North Carolina; Mayo Clinic, Jacksonville, FL (E.A.P.); University of Maryland School of Medicine, Baltimore (J.A.O.), and National Institutes of Health, Bethesda (J.Z., T.L.) - both in Maryland; Indiana University School of Medicine (S.S.B.) and Indiana University Hospital (G.W.S.) - both in Indianapolis; Vince Lombardi Cancer Clinic, Two Rivers (T.J.S.), and Fox Valley Hematology and Oncology, Appleton (T.F.G.) - both in Wisconsin; Baylor College of Medicine, Houston (M.J.E.), and University of Texas, San Antonio (P.R.) - both in Texas; Washington University, St. Louis (M.J.E.); Allegheny General Hospital (S.P.) and University of Pittsburgh (A.M.B.) - both in Pittsburgh; the Department of Medical Oncology and Breast Center, Yonsei University College of Medicine, Seoul, South Korea (S.P.); Emory University, Atlanta (W.C.W.); Irish Clinical Oncology Research Group, Dublin (M.M.K.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.M.); Cancer Center of Kansas, Wichita (P.S.R.); Vanderbilt University, Nashville (I.A.M.); Rutgers Cancer Institute of New Jersey, New Brunswick (D.L.T.); University of Hawaii Cancer Center, Honolulu (J.L.B.); and Stanford University, Stanford, CA (G.W.S.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701034PMC
November 2015

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2015 Aug 20;33(24):2695-704. Epub 2015 Jul 20.

Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Texas Oncology, Dallas, TX; Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA; Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC; Wanda Lucas, Georgetown University, Washington, DC; Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN; and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478102PMC
August 2015

Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.

Breast Cancer Res Treat 2015 Jul 7;152(1):163-172. Epub 2015 Jun 7.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3454-8DOI Listing
July 2015

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.

Clin Cancer Res 2015 Jun 7;21(11):2487-98. Epub 2014 Nov 7.

Breast Oncology Program of the Comprehensive Cancer Center and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516625PMC
June 2015

Validation of new cancer biomarkers: a position statement from the European group on tumor markers.

Clin Chem 2015 Jun 16;61(6):809-20. Epub 2015 Apr 16.

Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2015.239863DOI Listing
June 2015

Biomarker validation and testing.

Authors:
Daniel F Hayes

Mol Oncol 2015 May 18;9(5):960-6. Epub 2014 Oct 18.

University of Michigan Comprehensive Cancer Center, 6312 CCC, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5942, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.10.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528748PMC
May 2015

Reply to F.-C. Bidard et al.

J Clin Oncol 2015 May 13;33(14):1623. Epub 2015 Apr 13.

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.5519DOI Listing
May 2015

Genome Medicine in Cancer: What's in a Name?

Cancer Res 2015 May 28;75(10):1930-5. Epub 2015 Apr 28.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0174DOI Listing
May 2015

Indications for prognostic gene expression profiling in early breast cancer.

Curr Treat Options Oncol 2015 May;16(5):23

University of Michigan Comprehensive Cancer Center, 6312 CCC, 1500 East Medical Center Drive, SPC5942, Ann Arbor, MI, 48109-5942, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-015-0340-xDOI Listing
May 2015

Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?

J Natl Cancer Inst Monogr 2015 May;2015(51):36-9

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH, AFS).

View Article

Download full-text PDF

Source
https://academic.oup.com/jncimono/article-lookup/doi/10.1093
Publisher Site
http://dx.doi.org/10.1093/jncimonographs/lgv004DOI Listing
May 2015

Biomarkers and oncology: the path forward to a learning health system.

Arch Pathol Lab Med 2015 Apr 25;139(4):451-6. Epub 2014 Aug 25.

From the Department of Hematology-Oncology, Palo Alto Medical Foundation, Palo Alto, California (Dr Yu); the Center for Health Insights, University of Missouri, Kansas City (Dr Hoffman); and the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor (Dr Hayes).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0080-EDDOI Listing
April 2015

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.

J Clin Oncol 2014 Nov 2;32(31):3483-9. Epub 2014 Jun 2.

Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/06/02/JCO.2014.56
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.56.2561
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.56.2561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209100PMC
November 2014

Assessment of PIK3CA mutations in human epidermal growth factor receptor 2-positive breast cancer: clinical validity but not utility.

J Clin Oncol 2014 Oct 8;32(29):3207-9. Epub 2014 Sep 8.

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6132DOI Listing
October 2014

Molecular testing in breast cancer.

Annu Rev Med 2014 ;65:95-110

Breast Oncology Program of the Comprehensive Cancer Center, and the Department of Internal Medicine, University of Michigan Health and Hospital System, Ann Arbor, Michigan 48109; email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-070912-143853DOI Listing
September 2014

Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy.

Cancer 2014 Aug 6;120(16):2403-11. Epub 2014 May 6.

Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126845PMC
August 2014

Reply to R. Bhargava et al and K. Lambein et al.

J Clin Oncol 2014 Jun 28;32(17):1857-9. Epub 2014 Apr 28.

National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.0673DOI Listing
June 2014

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast.

Arch Pathol Lab Med 2014 May 15;138(5):595-601. Epub 2013 Nov 15.

From the Department of Pathology, St Jude Medical Center, Fullerton, California (Dr Fitzgibbons); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Kaiser Permanente-Los Angeles Medical Center, Los Angeles, California (Dr Alsabeh); the Department of Pathology, Jefferson Hospital, Jefferson Hills, Pennsylvania (Dr Berman); the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor (Dr Hayes); the Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York (Dr Hicks); the Division of Surgical Oncology, Massachusetts General Hospital, Boston (Dr Hughes); and the Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (Dr Nofech-Mozes).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0566-CPDOI Listing
May 2014

Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.

J Pain 2014 May 22;15(5):468-75. Epub 2014 Jan 22.

Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpain.2014.01.487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063362PMC
May 2014

Promoting quality and evidence-based care in early-stage breast cancer follow-up.

J Natl Cancer Inst 2014 Apr 13;106(4):dju034. Epub 2014 Mar 13.

Affiliations of authors: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI (NLH, DFH); Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA (SDR, JRG); Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (GNH); Department of Biostatistics, University of Washington, Seattle, WA (WEB).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/106/4/dju034.full.pdf
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju034
Publisher Site
http://dx.doi.org/10.1093/jnci/dju034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311189PMC
April 2014

Prediction of postchemotherapy ovarian function using markers of ovarian reserve.

Oncologist 2014 Jan 6;19(1):68-74. Epub 2013 Dec 6.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Department of Biostatistics, and Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903057PMC
January 2014

An international Ki67 reproducibility study.

J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.

Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888090PMC
December 2013

OMICS-based personalized oncology: if it is worth doing, it is worth doing well!

Authors:
Daniel F Hayes

BMC Med 2013 Oct 17;11:221. Epub 2013 Oct 17.

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, 6312 Cancer Center, 1500 E, Medical Center Drive, Ann Arbor, MI 48109-0942, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1741-7015-11-221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876724PMC
October 2013